Discusses the effects of expanding the Diagnostic and Statistical Manual of Mental Disorders (DSM)'s fourth edition on the psychiatric community, pharmaceutical companies, and the nation.
Genres
0
people already read
1
people are currently reading
3
people want to read
About the author